ATB — Antibiotice SA Income Statement
0.000.00%
Last trade - 00:00
- RON1.66bn
- RON1.72bn
- RON600.78m
- 78
- 28
- 59
- 55
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 390 | 340 | 366 | 483 | 601 |
Cost of Revenue | |||||
Gross Profit | 253 | 239 | 230 | 331 | 380 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 350 | 307 | 332 | 437 | 504 |
Operating Profit | 40 | 33.7 | 34 | 45.7 | 96.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 35.2 | 28.3 | 30.3 | 41.9 | 91.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 30.8 | 26.4 | 29.9 | 38.5 | 81.1 |
Net Income Before Extraordinary Items | |||||
Net Income | 30.8 | 26.4 | 29.9 | 38.5 | 81.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 30.8 | 26.4 | 29.9 | 38.5 | 81.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.046 | 0.039 | 0.045 | 0.057 | 0.121 |
Dividends per Share |